Advances in Oncologic Body and Breast Spectroscopy

16:30         126.      Evidence-Based Medicine: What’s Wrong with Spectroscopy Papers? - not available

Brian D. Ross¹

¹Huntington Medical Research Institutes, Pasadena, California, USA

16:42         127.      Relation Between ¹⁹F MR Spectroscopy of 5-FU, Dynamic Gadolinium-DTPA Uptake and Response to Treatment in Colorectal Liver Metastases - not available

Hanneke W.M. van Laarhoven¹, Dennis W.J. Klomp¹, Mark Rijpkema¹, Yvonne J. Kamm¹, D. J. Wagener¹,

Cornelis J.A. Punt¹, Arend Heerschap¹

¹University Medical Centre Nijmegen, Nijmegen, Gelderland, Netherlands

16:54         128.      Measurement of T₁ Values as a Step Towards Absolute Quantification of Capecitabine and Its Metabolites in Human Liver by in Vivo ¹⁹F MRS at 3 Tesla

Dennis W.J. Klomp¹, Hanneke W.M. van Laarhoven¹, Yvonne Kamm¹, Cees Punt¹, Arend Heerschap¹

¹Radboud University Nijmegen, Nijmegen, Netherlands

17:06         129.      High Phosphocholine in Breast Cancer; Metabolic-Molecular Elucidation - not available

Galit Eliyahu¹, Dalia Seger¹, Tamar Kreizmann¹, Hadassa Degani¹

¹Weizmann Institute of  Science, Rehovot, Israel

17:18         130.      HR MAS MRS: A Tool for Breast Cancer Grading? - not available

Tone F. Bathen¹, Line R. Jensen¹, Beathe Sitter¹, David E. Axelson², Steinar Lundgren¹, Jostein Halgunset³,

Hans E. Fjøsne¹, Ingrid S. Gribbestad¹

¹St. Olavs University Hospital, Trondheim, Norway; ²MRI Consulting, Kingston, Ontario, Canada; ³NTNU, Trondheim, Norway

17:30         131.      HR MAS MR Spectroscopy of Breast Cancer as a Predictive Tool for Lymph Node Status

Line R. Jensen¹, Tone F. Bathen¹, Beathe Sitter¹, David E Axelson², Steinar Lundgren¹, Jostein Halgunset³,

Hans E. Fjøsne¹, Ingrid S Gribbestad¹

¹St. Olavs University Hospital, Trondheim, Norway; ²MRI Consulting, Kingston, Ontario, Canada; ³Norwegian University of Science and Technology, Trondheim, Norway

17:42         132.      Using Quantitative Choline Measurements to Predict Axillary Node Status in Human Breast Cancer, in Vivo

Adeka McIntosh^1,2, Patrick J. Bolan^1,2, Sina Meisamy^1,2, Angela Styczynski^1,2, Lenore I. Everson¹, Michael T. Nelson¹, Tim H. Emory¹, Todd M. Tuttle¹, Doug Yee¹, Michael Garwood^1,2

¹University of Minnesota, Minneapolis, Minnesota, USA; ²Center for Magnetic Resonance Research, Minneapolis, Minnesota, USA

17:54         133.      Proton MRS at 1.5T Further Improves Specificity in Breast Cancer Detection Following Positive MRI Diagnosis

Wei Huang¹, Sunitha Thakur¹, Lia Bartella¹, Elizabeth Morris¹, Laura Liberman¹, Hedvig Hricak¹, Jason Koutcher¹,

D. David Dershaw¹

¹Memorial Sloan-Kettering Cancer Center, New York, New York, USA

18:06         134.      An Improved ¹H Magnetic Resonance Spectroscopic Imaging Technique for the Human Breast - not available

Jiani Hu¹, Yang Xuan, Zahid Latif, Renae L. Soulen

¹Wayne State Univeristy, Detroit, Michigan, USA

18:18         135.      Total Choline and Water Diffusion of C-neu /HER2 Mammary Carcinomas in Oncomice^® Assessed by in Vivo ¹H MRS

Basetti Madhu¹, Loreta M. Rodrigues¹, John R. Griffiths¹

¹St. George's Hospital Medical School, London, UK